A group of researchers from the University of Erlangen-Nuremberg has discovered which immune cells migrate from the skin of ...

Discover why psoriasis treatments may lose effectiveness and explore alternatives. Learn about the potential of biologics, ...

Metabolic bariatric surgery (MBS) is associated with improved outcomes in patients with psoriasis, according to a review ...

Psoriasis can increase skin infection risk due to effects from the condition and its treatments. Learn about potential infections, symptoms, and preventive measures.

Alumis Inc. surged on Phase 3 psoriasis data for envudeucitinib. Click for this look at ALMS stock and why I am bullish on ...

Arrowhead Pharmaceuticals disclosed that its gene-silencing candidates helped people with obesity lose fat, very early ...

Shares more than doubled in value after Phase 3 results suggested Alumis’ pill may compare favorably with other emerging oral ...

Alumis said on Tuesday its experimental drug met the main goal of improving symptoms of a common skin disease in two late-stage studies, powering its shares to a record high and more than doubling ...

Both Phase 3 trials met all primary and secondary endpoints with high statistical significance in patients with moderate-to-severe plaque ...

The global psoriasis treatment market, valued at $27 billion in 2024, is projected to nearly double to $58 billion by 2032, according to research firm Fortune Business Insights. Psoriasis is a chronic ...

An E.P.A. site listing the causes of climate change no longer includes the main one: human activity. By Lisa Friedman The Environmental Protection Agency has quietly removed the fact that human ...